PenderFund Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

PenderFund Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,380	Closed	-$318K	–	203
2022 Q3	$318K	Buy	+3,380	New	+$186K	0.1%	97

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

PenderFund Capital Management's GBT Position: Q4 2022 in Review

PenderFund Capital Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 3,380 shares — an estimated $318K sold.

PenderFund Capital Management first reported a position in GBT in Q3 2022 and held it in 1 quarter. The position peaked at $318K in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

PenderFund Capital Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
PenderFund Capital Management sold 3,380 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $318K.
PenderFund Capital Management first reported a position in Global Blood Therapeutics, Inc. in Q3 2022 and held it in 1 quarter.
PenderFund Capital Management's Global Blood Therapeutics, Inc. position peaked at $318K in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on PenderFund Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.